Pharma companies 'getting away with murder', says Trump

Comments knocked down shares of US biotech and pharmaceutical makers by about 2%

Donald Trump speaks during a press conference in Trump Tower, Manhattan, New York
US President-elect Donald Trump speaks during a press conference in Trump Tower, Manhattan, New York, US, January 11, 2017 (Photo: Reuters)
Reuters
Last Updated : Jan 11 2017 | 11:18 PM IST
US President-elect Donald Trump on Wednesday said pharmaceutical companies are "getting away with murder" in the prices that they charge the government for medicines, and promised that would change.

Trump has made few public comments about drug pricing since he was elected but his campaign platform had included allowing the Medicare healthcare program to negotiate with pharmaceutical companies, which the law currently prohibits.

The comments knocked down shares of biotech and pharmaceutical makers by about 2 per cent.

"We are going to start bidding. We are going to save billions of dollars over time," Trump said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Next Story